Literature DB >> 30289625

Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjects.

Yingjie Zhao1, Tingwei Guo1, Ania Fiksinski2,3, Elemi Breetvelt3, Donna M McDonald-McGinn4, Terrence B Crowley4, Alexander Diacou1, Maude Schneider5, Stephan Eliez5, Ann Swillen6, Jeroen Breckpot6, Joris Vermeesch6, Eva W C Chow7, Doron Gothelf8,9, Sasja Duijff2, Rens Evers10, Thérèse A van Amelsvoort10, Marianne van den Bree11, Michael Owen11, Maria Niarchou11, Carrie E Bearden12, Claudia Ornstein13, Maria Pontillo14, Antonino Buzzanca15, Stefano Vicari14, Marco Armando5,14, Kieran C Murphy16, Clodagh Murphy17, Sixto Garcia-Minaur18, Nicole Philip19, Linda Campbell20, Jaume Morey-Cañellas21, Jasna Raventos21, Jordi Rosell21, Damian Heine-Suner21, Robert J Shprintzen22, Raquel E Gur23, Elaine Zackai4, Beverly S Emanuel4, Tao Wang24, Wendy R Kates25, Anne S Bassett7,26, Jacob A S Vorstman3, Bernice E Morrow1.   

Abstract

The 22q11.2 deletion syndrome is caused by non-allelic homologous recombination events during meiosis between low copy repeats (LCR22) termed A, B, C, and D. Most patients have a typical LCR22A-D (AD) deletion of 3 million base pairs (Mb). In this report, we evaluated IQ scores in 1,478 subjects with 22q11.2DS. The mean of full scale IQ, verbal IQ, and performance IQ scores in our cohort were 72.41 (standard deviation-SD of 13.72), 75.91(SD of 14.46), and 73.01(SD of 13.71), respectively. To investigate whether IQ scores are associated with deletion size, we examined individuals with the 3 Mb, AD (n = 1,353) and nested 1.5 Mb, AB (n = 74) deletions, since they comprised the largest subgroups. We found that full scale IQ was decreased by 6.25 points (p = .002), verbal IQ was decreased by 8.17 points (p = .0002) and performance IQ was decreased by 4.03 points (p = .028) in subjects with the AD versus AB deletion. Thus, individuals with the smaller, 1.5 Mb AB deletion have modestly higher IQ scores than those with the larger, 3 Mb AD deletion. Overall, the deletion of genes in the AB region largely explains the observed low IQ in the 22q11.2DS population. However, our results also indicate that haploinsufficiency of genes in the LCR22B-D region (BD) exert an additional negative impact on IQ. Furthermore, we did not find evidence of a confounding effect of severe congenital heart disease on IQ scores in our cohort.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  22q11.2 deletion syndrome; IQ; deletion size; intellectual disability; low copy repeat; segmental duplication

Mesh:

Year:  2018        PMID: 30289625      PMCID: PMC6209529          DOI: 10.1002/ajmg.a.40359

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  63 in total

1.  Cognitive development in children with 22q11.2 deletion syndrome.

Authors:  Sasja N Duijff; Petra W J Klaassen; Henriette F N Swanenburg de Veye; Frits A Beemer; Gerben Sinnema; Jacob A S Vorstman
Journal:  Br J Psychiatry       Date:  2012-06       Impact factor: 9.319

2.  Velo-cardio-facial syndrome: language and psychological profiles.

Authors:  K J Golding-Kushner; G Weller; R J Shprintzen
Journal:  J Craniofac Genet Dev Biol       Date:  1985

3.  COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome.

Authors:  Doron Gothelf; Stephan Eliez; Tracy Thompson; Christine Hinard; Lauren Penniman; Carl Feinstein; Hower Kwon; Shuting Jin; Booil Jo; Stylianos E Antonarakis; Michael A Morris; Allan L Reiss
Journal:  Nat Neurosci       Date:  2005-10-23       Impact factor: 24.884

4.  Crk and Crk-like play essential overlapping roles downstream of disabled-1 in the Reelin pathway.

Authors:  Tae-Ju Park; Tom Curran
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

Review 5.  Genes, cognition and brain through a COMT lens.

Authors:  D Dickinson; B Elvevåg
Journal:  Neuroscience       Date:  2009-05-13       Impact factor: 3.590

Review 6.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

7.  Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome.

Authors:  B Morrow; R Goldberg; C Carlson; R Das Gupta; H Sirotkin; J Collins; I Dunham; H O'Donnell; P Scambler; R Shprintzen
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

8.  Comparison of normal and minimally brain dysfunctioned children on the McCarthy Scales of Children's Abilities.

Authors:  N L Kaufman; A S Kaufman
Journal:  J Clin Psychol       Date:  1974-01

9.  A comprehensive analysis of 22q11 gene expression in the developing and adult brain.

Authors:  T M Maynard; G T Haskell; A Z Peters; L Sikich; J A Lieberman; A-S LaMantia
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

10.  Mouse Models of 22q11.2-Associated Autism Spectrum Disorder.

Authors:  Noboru Hiroi; Takeshi Hiramoto; Kathryn M Harper; Go Suzuki; Shuken Boku
Journal:  Autism Open Access       Date:  2012
View more
  14 in total

Review 1.  Neurobiological perspective of 22q11.2 deletion syndrome.

Authors:  Janneke R Zinkstok; Erik Boot; Anne S Bassett; Noboru Hiroi; Nancy J Butcher; Claudia Vingerhoets; Jacob A S Vorstman; Therese A M J van Amelsvoort
Journal:  Lancet Psychiatry       Date:  2019-08-05       Impact factor: 27.083

2.  Okur-Chung neurodevelopmental syndrome-linked CK2α variants have reduced kinase activity.

Authors:  I Dominguez; J M Cruz-Gamero; V Corasolla; N Dacher; S Rangasamy; A Urbani; V Narayanan; H Rebholz
Journal:  Hum Genet       Date:  2021-05-04       Impact factor: 4.132

Review 3.  A genetics-first approach to understanding autism and schizophrenia spectrum disorders: the 22q11.2 deletion syndrome.

Authors:  Ania M Fiksinski; Gil D Hoftman; Jacob A S Vorstman; Carrie E Bearden
Journal:  Mol Psychiatry       Date:  2022-10-03       Impact factor: 13.437

4.  Protein kinase CK2 phosphorylates a conserved motif in the Notch effector E(spl)-Mγ.

Authors:  Lucas M Jozwick; Ashok P Bidwai
Journal:  Mol Cell Biochem       Date:  2022-09-10       Impact factor: 3.842

5.  The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia.

Authors:  Ralda Nehme; Olli Pietiläinen; Mykyta Artomov; Matthew Tegtmeyer; Vera Valakh; Leevi Lehtonen; Christina Bell; Tarjinder Singh; Aditi Trehan; John Sherwood; Danielle Manning; Emily Peirent; Rhea Malik; Ellen J Guss; Derek Hawes; Amanda Beccard; Anne M Bara; Dane Z Hazelbaker; Emanuela Zuccaro; Giulio Genovese; Alexander A Loboda; Anna Neumann; Christina Lilliehook; Outi Kuismin; Eija Hamalainen; Mitja Kurki; Christina M Hultman; Anna K Kähler; Joao A Paulo; Andrea Ganna; Jon Madison; Bruce Cohen; Donna McPhie; Rolf Adolfsson; Roy Perlis; Ricardo Dolmetsch; Samouil Farhi; Steven McCarroll; Steven Hyman; Ben Neale; Lindy E Barrett; Wade Harper; Aarno Palotie; Mark Daly; Kevin Eggan
Journal:  Nat Commun       Date:  2022-06-27       Impact factor: 17.694

Review 6.  Pathways to understanding psychosis through rare - 22q11.2DS - and common variants.

Authors:  Raquel E Gur; David R Roalf; Aaron Alexander-Bloch; Donna M McDonald-McGinn; Ruben C Gur
Journal:  Curr Opin Genet Dev       Date:  2021-02-08       Impact factor: 5.578

7.  Heterozygosity of murine Crkl does not recapitulate behavioral dimensions of human 22q11.2 hemizygosity.

Authors:  Takahira Yamauchi; Gina Kang; Noboru Hiroi
Journal:  Genes Brain Behav       Date:  2020-12-10       Impact factor: 3.449

8.  Social cognition in 22q11.2 deletion syndrome and idiopathic developmental neuropsychiatric disorders.

Authors:  Rhideeta Jalal; Aarti Nair; Amy Lin; Ariel Eckfeld; Leila Kushan; Jamie Zinberg; Katherine H Karlsgodt; Tyrone D Cannon; Carrie E Bearden
Journal:  J Neurodev Disord       Date:  2021-04-17       Impact factor: 4.025

9.  Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness.

Authors:  Christopher R K Ching; Boris A Gutman; Daqiang Sun; Julio Villalon Reina; Anjanibhargavi Ragothaman; Dmitry Isaev; Artemis Zavaliangos-Petropulu; Amy Lin; Rachel K Jonas; Leila Kushan; Laura Pacheco-Hansen; Ariana Vajdi; Jennifer K Forsyth; Maria Jalbrzikowski; Geor Bakker; Therese van Amelsvoort; Kevin M Antshel; Wanda Fremont; Wendy R Kates; Linda E Campbell; Kathryn L McCabe; Michael C Craig; Eileen Daly; Maria Gudbrandsen; Clodagh M Murphy; Declan G Murphy; Kieran C Murphy; Ania Fiksinski; Sanne Koops; Jacob Vorstman; T Blaine Crowley; Beverly S Emanuel; Raquel E Gur; Donna M McDonald-McGinn; David R Roalf; Kosha Ruparel; J Eric Schmitt; Elaine H Zackai; Courtney A Durdle; Naomi J Goodrich-Hunsaker; Tony J Simon; Anne S Bassett; Nancy J Butcher; Eva W C Chow; Fidel Vila-Rodriguez; Adam Cunningham; Joanne Doherty; David E Linden; Hayley Moss; Michael J Owen; Marianne van den Bree; Nicolas A Crossley; Gabriela M Repetto; Paul M Thompson; Carrie E Bearden
Journal:  Am J Psychiatry       Date:  2020-02-12       Impact factor: 18.112

Review 10.  Neurodevelopmental Trajectories and Psychiatric Morbidity: Lessons Learned From the 22q11.2 Deletion Syndrome.

Authors:  Ania M Fiksinski; Maude Schneider; Janneke Zinkstok; Danielle Baribeau; Samuel J R A Chawner; Jacob A S Vorstman
Journal:  Curr Psychiatry Rep       Date:  2021-02-24       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.